Evidence map›Paper›PMID 25304492›Full record

ReviewChemico-biological interactions2015

The aldo-keto reductases (AKRs): Overview.

Trevor M Penning

Abstract readReview
In one paragraph

Review in Chemico-biological interactions, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 219 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
219citing papers in PubMed, 2 pooled it
9.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

219 citing papers in PubMed, 2 syntheses or guidelines pooled it, 518 citations in OpenAlex.

  1. The Role ofGenes · 2026
    Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Epidermal retinoid starvation driven by AKR1B10 orchestrates barrier disruption and hyperinflammation in atopic dermatitis.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article

159 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Trevor M PenningCenter of Excellence in Environmental Toxicology, Department of Pharmacology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. Electronic address: penning@upenn.edu.
University of Pennsylvania · US

Funding

Translational Research Support CoreP30ES013508 · NIEHS · UNIVERSITY OF PENNSYLVANIA · PI Trevor M Penning · 2006 to 2026
$35.3M
DIHYDRODIOL DEHYDROGENASE AND THE ASPIRIN-LIKE DRUGSR01CA039504 · NCI · UNIVERSITY OF PENNSYLVANIA · PI PENNING, TREVOR M · 1986 to 2014
$3.8M
Structure/Function of Steroid Transforming AKR'sR01DK047015 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI PENNING, TREVOR M · 1994 to 2011
$3.2M
Human Aldo Keto Reductases and Steroid Hormone ActionR01CA090744 · NCI · UNIVERSITY OF PENNSYLVANIA · PI PENNING, TREVOR M · 2001 to 2011
$3.1M
NCI NIH HHS 1R01-CA39504NCI NIH HHS R01 CA039504NCI NIH HHS R01 CA090744NIDDK NIH HHS R01 DK047015NIEHS NIH HHS P30 ES013508NIEHS NIH HHS P30-ES013508
6 · The paper itself

Abstract

The aldo-keto reductase (AKR) protein superfamily contains >190 members that fall into 16 families and are found in all phyla. These enzymes reduce carbonyl substrates such as: sugar aldehydes; keto-steroids, keto-prostaglandins, retinals, quinones, and lipid peroxidation by-products. Exceptions include the reduction of steroid double bonds catalyzed by AKR1D enzymes (5β-reductases); and the oxidation of proximate carcinogen trans-dihydrodiol polycyclic aromatic hydrocarbons; while the β-subunits of potassium gated ion channels (AKR6 family) control Kv channel opening. AKRs are usually 37kDa monomers, have an (α/β)8-barrel motif, display large loops at the back of the barrel which govern substrate specificity, and have a conserved cofactor binding domain. AKRs catalyze an ordered bi bi kinetic mechanism in which NAD(P)H cofactor binds first and leaves last. In enzymes that favor NADPH, the rate of release of NADP(+) is governed by a slow isomerization step which places an upper limit on kcat. AKRs retain a conserved catalytic tetrad consisting of Tyr55, Asp50, Lys84, and His117 (AKR1C9 numbering). There is conservation of the catalytic mechanism with short-chain dehydrogenases/reductases (SDRs) even though they show different protein folds. There are 15 human AKRs of these AKR1B1, AKR1C1-1C3, AKR1D1, and AKR1B10 have been implicated in diabetic complications, steroid hormone dependent malignancies, bile acid deficiency and defects in retinoic acid signaling, respectively. Inhibitor programs exist world-wide to target each of these enzymes to treat the aforementioned disorders. Inherited mutations in AKR1C and AKR1D1 enzymes are implicated in defects in the development of male genitalia and bile acid deficiency, respectively, and occur in evolutionarily conserved amino acids. The human AKRs have a large number of nsSNPs and splice variants, but in many instances functional genomics is lacking. AKRs and their variants are now poised to be interrogated using modern genomic and informatics approaches to determine their association with human health and disease.

Indexed as

Aldehyde ReductaseAldo-Keto ReductasesCatalysisFatty Acid SynthasesHumansNADH, NADPH OxidoreductasesNADPOxidation-ReductionProtein Structure, TertiarySteroidsSubstrate SpecificityAldehyde ReductaseAldo-Keto ReductasesFatty Acid SynthasesNADH, NADPH OxidoreductasesNADPshort chain trans-2-enoyl-CoA reductaseSteroidsHydroxysteroid dehydrogenasesPotassium channelsQuinone reductaseSteroid 5β-reductaseXenobiotics

Identifiers

PMID25304492
PMCPMC4388799
OpenAlexW2078086567

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.